PL2520295T3 - Sposób zapobiegania i leczenia zapalenia błon śluzowych - Google Patents

Sposób zapobiegania i leczenia zapalenia błon śluzowych

Info

Publication number
PL2520295T3
PL2520295T3 PL12177486T PL12177486T PL2520295T3 PL 2520295 T3 PL2520295 T3 PL 2520295T3 PL 12177486 T PL12177486 T PL 12177486T PL 12177486 T PL12177486 T PL 12177486T PL 2520295 T3 PL2520295 T3 PL 2520295T3
Authority
PL
Poland
Prior art keywords
preventing
treating mucositis
mucositis
treating
Prior art date
Application number
PL12177486T
Other languages
English (en)
Inventor
Ezio Bombardelli
Paolo Morazzoni
Original Assignee
Indena S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37309334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2520295(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena S.P.A. filed Critical Indena S.P.A.
Publication of PL2520295T3 publication Critical patent/PL2520295T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PL12177486T 2006-07-28 2007-07-27 Sposób zapobiegania i leczenia zapalenia błon śluzowych PL2520295T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06015732A EP1882473A1 (en) 2006-07-28 2006-07-28 Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs

Publications (1)

Publication Number Publication Date
PL2520295T3 true PL2520295T3 (pl) 2017-02-28

Family

ID=37309334

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12177486T PL2520295T3 (pl) 2006-07-28 2007-07-27 Sposób zapobiegania i leczenia zapalenia błon śluzowych
PL07804655T PL2046324T3 (pl) 2006-07-28 2007-07-27 Leczenie i zapobieganie zapaleniu błon śluzowych pochodnymi antocyjanidyny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07804655T PL2046324T3 (pl) 2006-07-28 2007-07-27 Leczenie i zapobieganie zapaleniu błon śluzowych pochodnymi antocyjanidyny

Country Status (20)

Country Link
US (3) US20080026058A1 (pl)
EP (4) EP1882473A1 (pl)
JP (1) JP5433415B2 (pl)
KR (1) KR20090052852A (pl)
CN (1) CN101495114A (pl)
AU (1) AU2007278959B2 (pl)
BR (1) BRPI0715364A2 (pl)
CA (2) CA2659211C (pl)
DK (2) DK2520295T3 (pl)
ES (2) ES2602786T3 (pl)
HU (2) HUE031034T2 (pl)
IL (1) IL196737A (pl)
MX (1) MX2009001064A (pl)
NO (1) NO341742B1 (pl)
PL (2) PL2520295T3 (pl)
PT (2) PT2520295T (pl)
RU (1) RU2438693C2 (pl)
SG (1) SG172745A1 (pl)
SI (2) SI2520295T1 (pl)
WO (1) WO2008012666A2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042414A1 (it) * 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
ITMI20080038A1 (it) * 2008-01-11 2009-07-12 Indena Spa Formulazioni per il trattamento di mucositi indotte da terapia antitumorale o immunosoppressiva
ITMI20080395A1 (it) * 2008-03-10 2009-09-11 Indena Spa Formulazioni per il trattamento delle verruche e delle placche psoriatiche
AU2009240295B2 (en) * 2008-04-24 2014-03-06 Indena S.P.A. Compositions for the treatment of vaginal infections with chronic inflammation
EP2268276A1 (en) * 2008-04-24 2011-01-05 Indena S.p.A. Compositions for the treatment and prevention of infections of the oral cavity
SI2133079T1 (sl) * 2008-06-12 2012-01-31 Indena Spa Sestavek za zdravljenje vaginalnih infekcij s kroniäśnim vnetjem
ES2334746B1 (es) * 2008-07-23 2011-01-28 Feedback Trayer, S.L. Producto para la higiene intima a base de mirtillo rojo y procedimiento para su preparacion.
JP2010215532A (ja) * 2009-03-13 2010-09-30 Ands Corporation コラーゲンゲル収縮促進剤
JP2013508347A (ja) 2009-10-21 2013-03-07 マクイ ニュー ライフ ソシエダ アノニマ アントシアニジンを含む組成物及び使用方法
IT1402749B1 (it) 2010-10-28 2013-09-18 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
FR2979241B1 (fr) 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
CN104145966B (zh) * 2014-07-23 2016-09-07 中国人民解放军第二军医大学 白屈菜红碱在制备抗真菌生物被膜药物中的应用
JP6700084B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル コーティング顆粒
JP6700083B2 (ja) * 2016-03-30 2020-05-27 株式会社ファンケル 口腔内速崩壊錠
CN106361755A (zh) * 2016-10-23 2017-02-01 徐州诺克非医药科技有限公司 含Zoarenone用于治疗溃疡性结肠炎的药物
CN110636760B (zh) * 2016-10-27 2023-04-14 Nse产品公司 肠道健康促进组合物
CN108721276B (zh) * 2018-06-29 2020-01-07 佛山科学技术学院 一种小白菊内酯和原花青素复方药物组合物及其用途
CN109549946B (zh) * 2019-01-08 2020-12-18 牡丹江医学院 一种治疗咽炎的药物及其制备方法
CN117298094A (zh) * 2023-09-27 2023-12-29 青海瑞成药业(集团)有限公司 氯化矢车菊素协同氟康唑在制备抗耐药真菌的药物中的应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145412A (en) 1977-02-14 1979-03-20 Vipont Chemical Company Composition for application to oral cavity and method for preparation thereof
GB2062991B (en) * 1979-11-07 1983-11-16 Image Data Products Ltd Position co-ordinates digitiser
US4818533A (en) 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
IT1231725B (it) * 1989-08-11 1991-12-21 Inverni Della Beffa Spa Procedimento per la preparazione di estratti ad alto contenuto in antocianosidi.
ES2075187T3 (es) 1990-07-05 1995-10-01 Indena Spa Extractos de equinaceas, un procedimiento para su preparacion y formulaciones que los contienen.
JP2754906B2 (ja) * 1990-11-06 1998-05-20 日本電気株式会社 半導体集積回路
US5073368A (en) * 1991-05-15 1991-12-17 Colgate-Palmolive Company Sanguinaria mouthrinse having improved anti microbial activity and stability
US5378465A (en) 1993-05-24 1995-01-03 Zeines; Victor Solution for application to an oral cavity
IT1270999B (it) * 1994-07-26 1997-05-26 Indena Spa Formulazioni a base di cumarine e loro uso in campo farmaceutico e cosmetico
NO943860D0 (no) * 1994-10-13 1994-10-13 Unifob En kjemisk forbindelse og et preparat til bruk som terapeutikum
WO1997041137A1 (en) * 1996-04-17 1997-11-06 Unifob Use of anthocyanidin and anthocyanidin derivatives
US5840322A (en) 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
ITMI981542A1 (it) 1998-07-07 2000-01-07 Indena Spa Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche
US6162393A (en) 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
JP2001039844A (ja) * 1999-07-29 2001-02-13 Kikkoman Corp 咽喉用うがい剤
CN1384713A (zh) * 1999-08-27 2002-12-11 密执安州大学 包含天然的环加氧酶抑制剂的保健食品添加剂
ITMI20000628A1 (it) * 2000-03-24 2001-09-24 Indena Spa Composizioni cosmetiche ritardanti la ricrescita dei peli
AT500455B1 (de) * 2000-09-15 2007-08-15 Roth Hermann Dr Verwendung von benzophenanthridinalkaloiden als futteradditiv
ATE525061T1 (de) * 2001-02-28 2011-10-15 Axiomedic Ltd Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
AU2002311922A1 (en) 2001-05-15 2002-11-25 The Procter And Gamble Company Oral care compositions
IL143318A0 (en) * 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6596313B2 (en) * 2001-08-06 2003-07-22 The Quigley Corporation Nutritional supplement and methods of using it
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US20050222250A1 (en) * 2002-04-16 2005-10-06 Mohiaddin Rezvani Curcumin for the prevention and/or treatment of tissue damage
US7790762B2 (en) * 2002-10-31 2010-09-07 National Jewish Health Compounds and methods for thiol-containing compound efflux and cancer treatment
GB0230042D0 (en) * 2002-12-23 2003-01-29 Britannia Pharmaceuticals Ltd Composition comprising plant extract and a sugar for use in inhibiting bacterial proliferation
FR2856304B1 (fr) * 2003-06-20 2006-03-03 Natural Product Consulting Composition pour la prevention des infections du systeme urinaire
ITMI20032287A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento delle affezioni del cavo orale e delle prime vie respiratorie
DK1747008T3 (en) * 2004-04-28 2015-03-30 Nutrition Science Partners Ltd Crude extract FROM Andrographis paniculata
WO2006024545A1 (en) * 2004-09-03 2006-03-09 Stichting Voor De Technische Wetenschappen Fused bicyclic natural compounds and their use as inhibitors of parp and parp-mediated inflammatory processes
ITMI20042414A1 (it) 2004-12-17 2005-03-17 Indena Spa Formulazione per il trattamento di affezioni delle prime vie respiratorie
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
CA2622286A1 (en) * 2005-09-27 2007-04-05 University Of Kentucky Research Foundation Anti-inflammatory composition comprising berry extract

Also Published As

Publication number Publication date
ES2602786T3 (es) 2017-02-22
WO2008012666A2 (en) 2008-01-31
CA2935902A1 (en) 2008-01-31
EP2520295A1 (en) 2012-11-07
HUE031941T2 (en) 2017-08-28
CN101495114A (zh) 2009-07-29
JP5433415B2 (ja) 2014-03-05
MX2009001064A (es) 2009-02-05
CA2659211A1 (en) 2008-01-31
EP2046324A2 (en) 2009-04-15
KR20090052852A (ko) 2009-05-26
US20170304341A1 (en) 2017-10-26
NO341742B1 (no) 2018-01-15
CA2659211C (en) 2016-08-16
EP1882473A1 (en) 2008-01-30
EP2520295B1 (en) 2016-08-17
RU2009102649A (ru) 2010-08-10
WO2008012666A3 (en) 2008-09-04
RU2438693C2 (ru) 2012-01-10
PT2520295T (pt) 2016-11-21
AU2007278959B2 (en) 2013-03-28
CA2935902C (en) 2019-02-19
PT2046324T (pt) 2017-07-03
SI2520295T1 (sl) 2016-11-30
US20080026058A1 (en) 2008-01-31
SG172745A1 (en) 2011-07-28
DK2520295T3 (en) 2016-12-12
US20100310684A1 (en) 2010-12-09
JP2009544687A (ja) 2009-12-17
EP2522345A1 (en) 2012-11-14
HUE031034T2 (en) 2017-06-28
NO20090887L (no) 2009-02-26
SI2046324T1 (sl) 2017-06-30
DK2046324T3 (en) 2017-06-12
AU2007278959A1 (en) 2008-01-31
BRPI0715364A2 (pt) 2013-06-18
IL196737A (en) 2014-05-28
ES2629306T3 (es) 2017-08-08
PL2046324T3 (pl) 2017-09-29
IL196737A0 (en) 2009-11-18
EP2046324B1 (en) 2017-04-05
US9730952B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
PT2520295T (pt) Métodos para prevenir e tratar a mucosite
BRPI0716500A2 (pt) Projétil e método de direcionamento de projétil
FI20075978A0 (fi) Järjestely ja menetelmä
BRPI0717389A2 (pt) Dispositivos e métodos para avanço de stent
EP2021576A4 (en) EXTENSION TUBE AND METHOD OF MANUFACTURE
FI20065359A0 (fi) Menetelmä ja rannelaite
BRPI0820474A2 (pt) método de tratamento de uma doença, uso de composto, e, composto
FI20065348A0 (fi) Spektrometri ja inferferometrinen menetelmä
EP2030517A4 (en) SWIMSUIT AND METHOD OF MANUFACTURING THE SAME
DE602007010225D1 (de) Synchronisationsverfahren und -anordnung
EP2079544A4 (en) ARSENIC ABSORBENT COMPOSITION AND METHODS OF USE
BRPI0716475A2 (pt) composições e método anticorpos anti-sc1 para tratar múltiplos mielomas
BRPI0717073A2 (pt) Composição detergente e método
DE602007000367D1 (de) Aufgekohlte Komponente und Herstellungsverfahren dafür
FI20040675A0 (fi) Menetelmä sydämen hypertrofian hoitoon ja estoon
NO20075424L (no) Fremgangsmate og anvendelse
EP2132251A4 (en) COMPOSITION AND METHOD
FI20055682A0 (fi) Läpivientiosa sekä menetelmä
BRPI0715087A2 (pt) Método de tratamento de disfunção termoregulatória com paroxetina
DE602007000373D1 (de) Trennbeschichtung und entsprechendes Verfahren
FI20055308L (fi) Turbokompressorin turpiiniosa ja menetelmä turbokompressorin turpiiniosan karstoittumisen estämiseksi
FI20060094L (fi) Polttomenetelmä ja polttolaite
FI20065170L (fi) Menetelmä ja sovitelma sillan siirtämiseksi
FI20075357L (fi) Menetelmä ja sovitelma päättymättömän kudoksen kunnostamiseksi
EP1992992A4 (en) TONER AND METHOD FOR MANUFACTURING THE SAME